Nephrocare Health Services' Q4 FY 2025-26 Quarterly Results

Result Summary

• Nephrocare Health Services Ltd reported a 5.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.
• Its expenses for the quarter were up by 6.3% QoQ and - - YoY.
• The net profit decreased 5.8% QoQ and - - YoY.
• The earnings per share (EPS) of Nephrocare Health Services Ltd stood at 2.96 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Nephrocare Health Services Ltd is a company operating within the healthcare industry, primarily focusing on providing renal care services. The company is likely engaged in offering dialysis treatments and related healthcare services to patients with kidney disorders. Although specific details about Nephrocare's recent developments or expansions are not available, companies in this sector typically focus on enhancing service quality, expanding their network of clinics, and adopting advanced technology to improve patient outcomes. Nephrocare Health Services Ltd operates in an industry characterized by a growing demand for specialized healthcare services, driven by increasing incidences of chronic kidney diseases and a rising geriatric population.

Revenue

In the fourth quarter of fiscal year 2026 (Q4FY26), Nephrocare Health Services Ltd reported a total income of ₹277.18 crores. This represents an increase of 5.4% quarter-over-quarter (QoQ) from the third quarter of fiscal year 2026 (Q3FY26), where the company recorded a total income of ₹263.04 crores. Year-over-year (YoY) data is not available for comparison as the total income for the fourth quarter of fiscal year 2025 (Q4FY25) is not provided. The growth in total income on a QoQ basis suggests increased revenue generation, possibly due to higher patient volumes or expanded service offerings.

Profitability

For the profitability metrics, Nephrocare Health Services Ltd recorded a profit before tax of ₹36.31 crores in Q4FY26, showing a marginal decrease of 0.1% QoQ compared to ₹36.36 crores in Q3FY26. The tax expense for Q4FY26 was ₹2.85 crores, a significant decrease of 30.8% from ₹4.12 crores in Q3FY26. Consequently, the profit after tax for Q4FY26 was ₹30.37 crores, down 5.8% from ₹32.24 crores in Q3FY26. Earnings per share (EPS) stood at ₹2.96 in Q4FY26, down 11.6% from ₹3.35 in Q3FY26. Although YoY comparisons are not possible due to incomplete data, the QoQ changes indicate fluctuations in profitability.

Operating Metrics

The total expenses for Nephrocare Health Services Ltd in Q4FY26 amounted to ₹240.87 crores, reflecting an increase of 6.3% QoQ from ₹226.68 crores in Q3FY26. This rise in expenses outpaced the growth in total income, impacting the overall profitability for the quarter. Key financial ratios, such as the P/E ratio, debt-to-equity ratio, and current ratio, are not calculable from the provided data, as necessary inputs like share price, total debt, and current assets/liabilities are missing. However, the available data highlights an increase in operational costs, which is a critical factor affecting the company's financial performance during the quarter.